| Financial Year |
March 31 2023 |
| Monetary Funds |
3,466,725,811.19 |
| Held-for-trading Financial Assets |
691,228,294.80 |
| Notes Receivable |
1,959,850.91 |
| Accounts Receivable |
849,704,067.21 |
| Advances to Suppliers |
47,058,787.99 |
| Other Receivables |
12,619,855.51 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
973,230,320.21 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,216,509,165.46 |
| Total Current Assets |
8,397,891,426.57 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,039,073,528.83 |
| Under-construction Projects |
495,664,562.79 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
148,353,817.88 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
62,377,650.17 |
| Deferred Income Tax Assets |
21,938,698.89 |
| Other Non-Current Assets |
7,602,585.22 |
| Sub-Total of Non-Current Assets |
1,778,831,903.89 |
| Total Assets |
10,176,723,330.46 |
| Short-Term Loans |
1,253,746,806.57 |
| Trading Financial liabilities |
14,195,540.00 |
| Notes Payable |
971,812,536.03 |
| Accounts Payable |
1,259,961,684.45 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
89,824,854.12 |
| Taxes Payable |
117,159,554.24 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
12,995,378.56 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
420,438,074.77 |
| Other Current Liabilities |
13,699,130.18 |
| Sub-Total of Current Liabilities |
4,599,526,685.37 |
| Long-term Loans |
930,686,301.38 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,789,094.36 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
977,886,855.31 |
| Total Liabilities |
5,577,413,540.68 |
| Paid-In Capital(Or Share Stock) |
238,933,800.00 |
| Capital Surplus |
1,354,399,011.40 |
| Surplus Reserve |
119,466,900.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,886,514,673.56 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,599,309,789.78 |
| Owner's Equity（Stockholder's Equity） |
4,599,309,789.78 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,176,723,330.46 |
